Infinity Pharmaceuticals (INFI)

Add to Watchlists Create an Alert
24.30 -0.06  -0.25%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Infinity Pharmaceuticals Shareholders Equity:

310.20M for Dec. 31, 2012
View Full Chart

Infinity Pharmaceuticals Shareholders Equity Chart

    Infinity Pharmaceuticals Historical Shareholders Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 310.20M
    Sept. 30, 2012 179.73M
    June 30, 2012 -3.392M
    March 31, 2012 6.963M
    Dec. 31, 2011 15.43M
    Sept. 30, 2011 28.07M
    June 30, 2011 38.38M
    March 31, 2011 48.56M
    Dec. 31, 2010 49.48M
    Sept. 30, 2010 76.21M
    June 30, 2010 95.48M
    March 31, 2010 99.63M
    Dec. 31, 2009 90.31M
    Sept. 30, 2009 112.70M
    June 30, 2009 120.42M
    March 31, 2009 130.22M
    Dec. 31, 2008 120.30M
    Sept. 30, 2008 32.32M
    June 30, 2008 43.24M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About Shareholders' Equity

    Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
    Learn More

    Get data for

    INFI Shareholders Equity Benchmarks

    Companies
    Ariad Pharmaceuticals 363.98M
    Halozyme Therapeutics 48.85M
    Synageva BioPharma

    INFI Shareholders Equity Rankings

    Overall 71st percentile
    2261 of 8009
    Sector 78th percentile
    150 of 687 in Healthcare
    Industry 90th percentile
    24 of 248 in Biotechnology

    INFI Shareholders Equity Range, Past 5 Years

    Minimum -3.392M Jun 2012
    Maximum 310.20M Dec 2012
    Average 83.91M